Correlation Between Indaptus Therapeutics and Better Therapeutics
Can any of the company-specific risk be diversified away by investing in both Indaptus Therapeutics and Better Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Indaptus Therapeutics and Better Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Indaptus Therapeutics and Better Therapeutics, you can compare the effects of market volatilities on Indaptus Therapeutics and Better Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Indaptus Therapeutics with a short position of Better Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Indaptus Therapeutics and Better Therapeutics.
Diversification Opportunities for Indaptus Therapeutics and Better Therapeutics
0.47 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Indaptus and Better is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding Indaptus Therapeutics and Better Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Better Therapeutics and Indaptus Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Indaptus Therapeutics are associated (or correlated) with Better Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Better Therapeutics has no effect on the direction of Indaptus Therapeutics i.e., Indaptus Therapeutics and Better Therapeutics go up and down completely randomly.
Pair Corralation between Indaptus Therapeutics and Better Therapeutics
Given the investment horizon of 90 days Indaptus Therapeutics is expected to generate 0.84 times more return on investment than Better Therapeutics. However, Indaptus Therapeutics is 1.2 times less risky than Better Therapeutics. It trades about -0.01 of its potential returns per unit of risk. Better Therapeutics is currently generating about -0.04 per unit of risk. If you would invest 249.00 in Indaptus Therapeutics on August 26, 2024 and sell it today you would lose (149.00) from holding Indaptus Therapeutics or give up 59.84% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 14.21% |
| Values | Daily Returns |
Indaptus Therapeutics vs. Better Therapeutics
Performance |
| Timeline |
| Indaptus Therapeutics |
| Better Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Indaptus Therapeutics and Better Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Indaptus Therapeutics and Better Therapeutics
The main advantage of trading using opposite Indaptus Therapeutics and Better Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Indaptus Therapeutics position performs unexpectedly, Better Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Better Therapeutics will offset losses from the drop in Better Therapeutics' long position.| Indaptus Therapeutics vs. Rezolute | Indaptus Therapeutics vs. Tempest Therapeutics | Indaptus Therapeutics vs. Forte Biosciences | Indaptus Therapeutics vs. ABVC Biopharma |
| Better Therapeutics vs. ABVC Biopharma | Better Therapeutics vs. Indaptus Therapeutics | Better Therapeutics vs. Pasithea Therapeutics Corp | Better Therapeutics vs. Forte Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |